⌘K

Login Start Free

Home/Filings/4/0001209191-21-069043

4//SEC Filing

Hoos Axel 4

Accession 0001209191-21-069043

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:31 PM ET

Size

5.3 KB

Accession

0001209191-21-069043

Insider Transaction Report

Form 4

Period: 2021-12-09

TCR2 THERAPEUTICS INC.TCRR

Director

Transactions

Award
Stock Option (Right to Buy)
2021-12-09+12,100→ 12,100 total
Exercise: $5.21Exp: 2031-12-08→ Common Stock (12,100 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1

filerCIK 0001809415

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 4:31 PM ET
Size: 5.3 KB

View on SEC.gov